JP2024508753A5 - - Google Patents
Info
- Publication number
- JP2024508753A5 JP2024508753A5 JP2023549596A JP2023549596A JP2024508753A5 JP 2024508753 A5 JP2024508753 A5 JP 2024508753A5 JP 2023549596 A JP2023549596 A JP 2023549596A JP 2023549596 A JP2023549596 A JP 2023549596A JP 2024508753 A5 JP2024508753 A5 JP 2024508753A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- enzyme
- composition according
- infection
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163150433P | 2021-02-17 | 2021-02-17 | |
| US63/150,433 | 2021-02-17 | ||
| PCT/US2022/016771 WO2022178110A2 (en) | 2021-02-17 | 2022-02-17 | Dnase 1-like 2 engineered for manufacturing and use in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508753A JP2024508753A (ja) | 2024-02-28 |
| JP2024508753A5 true JP2024508753A5 (enExample) | 2025-02-19 |
Family
ID=82932330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023549596A Pending JP2024508753A (ja) | 2021-02-17 | 2022-02-17 | 製造及び療法への使用のために改変されたｄｎａｓｅ１－ｌｉｋｅ２ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240228995A9 (enExample) |
| EP (1) | EP4294824A4 (enExample) |
| JP (1) | JP2024508753A (enExample) |
| KR (1) | KR20240004247A (enExample) |
| CN (1) | CN117177990A (enExample) |
| WO (1) | WO2022178110A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112996911A (zh) * | 2018-10-08 | 2021-06-18 | 纽特雷斯股份有限公司 | 用于制造和疗法的脱氧核糖核酸酶的工程改造 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013151664A1 (en) * | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins |
| UA129696C2 (uk) * | 2017-08-18 | 2025-07-09 | Ньютроліс Інк. | СКОНСТРУЙОВАНІ ФЕРМЕНТИ ДНКази ТА ЇХНЄ ЗАСТОСУВАННЯ В ТЕРАПІЇ |
| AU2018393110B2 (en) * | 2017-12-20 | 2023-04-27 | Poseida Therapeutics, Inc. | VCAR compositions and methods for use |
| CN112996911A (zh) * | 2018-10-08 | 2021-06-18 | 纽特雷斯股份有限公司 | 用于制造和疗法的脱氧核糖核酸酶的工程改造 |
| US20220025343A1 (en) * | 2019-02-04 | 2022-01-27 | Neutrolis, Inc. | Engineered human extracellular dnase enzymes for drug candidate selection |
-
2022
- 2022-02-17 KR KR1020237031177A patent/KR20240004247A/ko active Pending
- 2022-02-17 CN CN202280029044.XA patent/CN117177990A/zh active Pending
- 2022-02-17 WO PCT/US2022/016771 patent/WO2022178110A2/en not_active Ceased
- 2022-02-17 JP JP2023549596A patent/JP2024508753A/ja active Pending
- 2022-02-17 US US18/546,864 patent/US20240228995A9/en active Pending
- 2022-02-17 EP EP22756915.9A patent/EP4294824A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008512117A5 (enExample) | ||
| US11446354B2 (en) | Method of treatment | |
| WO2020052677A1 (en) | New conjugates of montelukast and peptides | |
| JP2019513689A (ja) | 皮膚の創傷、障害、及び疾患を処置するための組成物及び方法 | |
| JP2024010006A5 (enExample) | ||
| US20250057927A1 (en) | Alpha-1 antitrypsin produced from yeast for use in the treatment of viral infections | |
| US20040171544A1 (en) | Trefoil domain-containing polypeptides and uses thereof | |
| US20060188471A1 (en) | Methods of treating epithelial lesions | |
| CN112877294A (zh) | 基因修饰的间充质干细胞外泌体的制备及其应用 | |
| WO2023155342A1 (zh) | 一种用于防治呼吸道疾病的雾化吸入制剂及其应用 | |
| CN118725084A (zh) | 一种重组xiv型胶原蛋白及其制备方法和应用 | |
| JP2007505159A5 (enExample) | ||
| WO2018171535A1 (zh) | 重组人胰岛素原融合蛋白及其制备方法和用途 | |
| US20240228995A9 (en) | Dnase 1-like 2 engineered for manufacturing and use in therapy | |
| CN110511285A (zh) | 一种重组融合多肽及其应用 | |
| CN103897034B (zh) | 一种预防和/或治疗炎症反应的小分子多肽及其应用 | |
| CN100535005C (zh) | 长链人胰岛素样生长因子(lr3igf-1)及其制备和应用方法 | |
| WO1995007710A1 (en) | Remedy for wound | |
| Schröder | Clinical significance of epithelial peptide antibiotics | |
| JP2006516964A (ja) | 三つ葉型ドメイン含有ポリペプチドおよびその使用 | |
| CN103087153B (zh) | 一类新的抑制新生血管的小肽及其应用 | |
| CN104371003A (zh) | 预防和治疗炎症的小分子多肽及其应用 | |
| KR20230167624A (ko) | 알로페론을 포함하는 항바이러스 조성물 | |
| Šaranović | Ectoine nasal spray in treatment of allergic rhinitis | |
| CN121405773A (zh) | 多巴修饰Fej衍生肽及其应用 |